0001213900-16-014439.txt : 20160622
0001213900-16-014439.hdr.sgml : 20160622
20160622173725
ACCESSION NUMBER: 0001213900-16-014439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160616
FILED AS OF DATE: 20160622
DATE AS OF CHANGE: 20160622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krumeich Karen R
CENTRAL INDEX KEY: 0001334797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 161727260
MAIL ADDRESS:
STREET 1: 3 WEST MAIN STREET
STREET 2: SUITE 201
CITY: IRVINGTON
STATE: NY
ZIP: 10533
4
1
f4061616krumeich_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2016-06-16
0
0000812796
SOLIGENIX, INC.
SNGX
0001334797
Krumeich Karen R
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
0
1
0
0
SVP and CFO
Option (Right to Buy)
0.74
2016-06-16
4
A
0
100000
0
A
2016-06-16
2026-06-15
Common Stock
100000
100000
D
The stock option vested immediately as to 25,000 shares and vests as to the remainder at a rate of 6,250 of the shares on each three (3) month anniversary of June 16, 2016.
/s/ Karen R. Krumeich
2016-06-22